TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: No More Shifts Planned For Treatment Programs; Groups Seek Surgeon, Radiologist Incentives August 29, 1975
TCL Archive Proposed HHS Conflict of Interest Rules May Require More Disclosure by Researchers May 15, 2009
